Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Distinguishing between chondroblastic osteosarcoma (CO), other osteosarcomas (OS), and chondrosarcomas (CS) is crucial for effective treatment.
• Magnetic resonance imaging (MRI) techniques, including contrast-enhanced MRI and diffusion-weighted imaging (DWI), are vital for characterizing bone tumors.

Purpose of the Study:

• To evaluate the efficacy of gadolinium-enhanced MRI versus DWI in differentiating chondroblastic osteosarcoma from other osteosarcomas and chondrosarcomas.
• To identify unique imaging features of chondroblastic osteosarcoma using advanced MRI sequences.

Main Methods:

• Contrast-enhanced MRI and DWI were performed on patients with CO, other OS, and CS.
• Apparent diffusion coefficients (ADCs) were calculated from DWI using a single-shot echo-planar imaging sequence.
• Enhancement patterns and ADC values (minimum and maximum) were analyzed and compared across tumor types.

Main Results:

• Chondroblastic osteosarcoma and chondrosarcoma exhibited similar contrast enhancement patterns (septonodular and peripheral rim).
• The minimum ADC value of CO was significantly higher than other OS but lower than CS.
• The maximum ADC value of CO was significantly higher than other OS.

Conclusions:

• Diffusion-weighted imaging (DWI) shows greater utility than gadolinium-enhanced MRI in differentiating chondroblastic osteosarcoma from chondrosarcoma and other osteosarcomas.
• ADC values derived from DWI provide valuable quantitative metrics for distinguishing these bone tumor subtypes.